0001564590-17-021820 Sample Contracts

Amendment No. 2 to the Executive Severance Benefits Agreement

Severance Benefits Agreement • November 6th, 2017 • Five Prime Therapeutics Inc • Pharmaceutical preparations

• Contract Type
  Severance Benefits Agreement
• Filed
  November 6th, 2017
• Company
  Five Prime Therapeutics Inc
• Industry
  Pharmaceutical preparations

This Amendment No. 2 to the Executive Severance Benefits Agreement (this “Amendment”), effective January 1, 2018 (the “Amendment Effective Date”), is made and entered into by and between Five Prime Therapeutics, Inc., a Delaware corporation (“FivePrime”), and Aron Knickerbocker, an individual (“Executive”).